IP Library Patent Application 13561911
Patent Application
App. No. 13/561,911

SERICIN EXTRACTED FABRICS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/561,911
Abstract

Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.

Claims (4)

1 . A fabric comprising one or more individual yarns comprised of sericin-extracted native fibroin fibers.

2 . A method for strengthening an injured area of a subject following surgery comprising implanting a fabric of claim 1 in contact with the injured area.

3 . The method of claim 2 , wherein the injured area comprises an organ.

4 . The method of claim 2 , wherein implanting is selected from the group consisting of sewing, stapling, gluing, and laying in place without tensioning.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 16, 2017
From: TUFTS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 041269/0081 →